Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1980 Nov;18(5):761–765. doi: 10.1128/aac.18.5.761

Synthesis of 3-O-demethylfortimicins.

J R Martin, P Johnson, J Tadanier, A Goldstein
PMCID: PMC284088  PMID: 6778386

Abstract

Treatment of fortimicin B with lithium in ethylamine gave 3-O-demethylfortimicin B. The latter was converted by methodology developed with fortimicin B to 3-O-demethylfortimicin A, 4-N-sarcosyl-3-O-demethylfortimicin B, 4-N-beta-alanyl-3-O-demethylfortimicin B, and 4-N-(beta-aminoethyl)-3-O-demethylfortimicin B. 3-O-demethylfortimicin A and the 4-N-acyl-3-O-demethylfortimicins B had appreciably higher antibacterial activities than the corresponding parent fortimicins. Most significant was the increased activity of 3-O-demethylfortimicin A relative to fortimicin A against a variety of strains of Pseudomonas aeruginosa.

Full text

PDF
764

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Egan R. S., Stanaszek R. S., Cirovic M., Mueller S. L., Tadanier J., Martin J. R., Collum P., Goldstein A. W., De Vault R. L., Sinclair A. C. Fortimicins A and B, new aminoglycoside antibiotics. III. Structural identification. J Antibiot (Tokyo) 1977 Jul;30(7):552–563. doi: 10.7164/antibiotics.30.552. [DOI] [PubMed] [Google Scholar]
  2. Girolami R. L., Stamm J. M. Comparative antimicrobial activity of O-demethylfortimicin A, a derivative of fortimicin A. Antimicrob Agents Chemother. 1980 Nov;18(5):766–772. doi: 10.1128/aac.18.5.766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Girolami R. L., Stamm J. M. Fortimicins A and B, new aminoglycoside antibiotics. IV. In vitro study of fortimicin A compared with other aminoglycosides. J Antibiot (Tokyo) 1977 Jul;30(7):564–570. doi: 10.7164/antibiotics.30.564. [DOI] [PubMed] [Google Scholar]
  4. Jones R. N., Barry A. L., Fuchs P. C., Gavan T. L., Sommers H. M., Gerlach E. H. Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolates. Antimicrob Agents Chemother. 1979 Dec;16(6):823–828. doi: 10.1128/aac.16.6.823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Jones R. N., Thornsberry C., Barry A. L., Packer R. R., Baker C. N., Badal R. E. Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics. Antimicrob Agents Chemother. 1980 Nov;18(5):773–779. doi: 10.1128/aac.18.5.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Nara T., Yamamoto M., Kawamoto I., Takayama K., Okachi R., Takasawa S., Sato T., Sato S. Fortimicins A and B, new aminoglycoside antibiotics. I. Producing organism, fermentation and biological properties of fortimicins. J Antibiot (Tokyo) 1977 Jul;30(7):533–540. doi: 10.7164/antibiotics.30.533. [DOI] [PubMed] [Google Scholar]
  7. Sato M., Mori Y. Chemical modification of fortimicins: preparation of 4-N-substituted fortimicin B. J Antibiot (Tokyo) 1979 Apr;32(4):371–378. doi: 10.7164/antibiotics.32.371. [DOI] [PubMed] [Google Scholar]
  8. Tadanier J., Martin J. R., Kurath P., Goldstein A. W., Johnson P. 4-N-acylfortimicins B and the preparation of fortimicin A from fortimicin B. Carbohydr Res. 1980 Feb;79(1):91–102. doi: 10.1016/s0008-6215(00)85134-4. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES